Try

Nuvation Bio Inc.

NUVBUnited States

25 filed reports · 378 financial concepts · 1 earnings calls · 0 media appearances

Filed reports

25 reports · Jun 2020 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR192,619Jun 2020 to Jun 2026
Annual · 10-KSEC EDGAR51,897Dec 2021 to Dec 2025
Annual · 10-K/ASEC EDGAR161Dec 2020

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Aug 6, 2026360Open
FY2026 Q110-QMar 31, 2026May 4, 2026221Open
FY202510-KDec 31, 2025Mar 2, 2026644Open
FY2025 Q310-QSep 30, 2025Nov 3, 2025272Open
FY2025 Q210-QJun 30, 2025Aug 7, 2025157Open
FY2025 Q110-QMar 31, 2025May 7, 2025140Open
FY202410-KDec 31, 2024Mar 6, 2025361Open
FY2024 Q310-QSep 30, 2024Nov 6, 2024153Open
FY2024 Q210-QJun 30, 2024Aug 5, 2024126Open
FY2024 Q110-QMar 31, 2024May 14, 2024120Open
FY202310-KDec 31, 2023Feb 29, 2024293Open
FY2023 Q310-QSep 30, 2023Nov 2, 2023137Open

Financial data

378 concepts · 4,577 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial370 concepts · 4,464 facts · Dec 2019 to Aug 2026

  • Warrant liability40 · Dec 2020 to Jun 2026
  • Accumulated other comprehensive income loss net of tax32 · Mar 2020 to Jun 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Mar 2020 to Jun 2026
  • Allocated share based compensation expense32 · Mar 2020 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents32 · Mar 2020 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect32 · Mar 2020 to Jun 2026
  • Comprehensive income net of tax32 · Mar 2020 to Jun 2026
  • Depreciation and amortization32 · Mar 2020 to Jun 2026
  • Increase decrease in accounts payable32 · Mar 2020 to Jun 2026
  • Increase decrease in accrued liabilities32 · Mar 2020 to Jun 2026
  • Increase decrease in interest and dividends receivable32 · Mar 2020 to Jun 2026
  • Interest income other32 · Mar 2020 to Jun 2026
  • Marketable securities unrealized gain loss32 · Mar 2020 to Jun 2026
  • Net cash provided by used in investing activities32 · Mar 2020 to Jun 2026
  • Net cash provided by used in operating activities32 · Mar 2020 to Jun 2026
  • Net income loss32 · Mar 2020 to Jun 2026
  • Nonoperating income expense32 · Mar 2020 to Jun 2026
  • Operating expenses (US GAAP)32 · Mar 2020 to Jun 2026
  • Operating income loss32 · Mar 2020 to Jun 2026
  • Other comprehensive income loss net of tax32 · Mar 2020 to Jun 2026
  • Payments to acquire machinery and equipment32 · Mar 2020 to Jun 2026
  • Payments to acquire marketable securities32 · Mar 2020 to Jun 2026
  • Proceeds from sale and maturity of marketable securities32 · Mar 2020 to Jun 2026
  • Professional fees32 · Mar 2020 to Jun 2026

Geography4 concepts · 71 facts · Dec 2021 to Jun 2026

  • Revenue33 · Jun 2024 to Jun 2026
  • New York City24 · Dec 2021 to Mar 2026
  • Revenue (including assessed tax)11 · Sep 2024 to Dec 2025
  • Revenue from contract with customer including assessed tax3 · Sep 2025

Product4 concepts · 42 facts · Jun 2024 to Jun 2026

  • Revenue36 · Jun 2024 to Jun 2026
  • Contract with customer liability revenue recognized3 · Dec 2025 to Jun 2026
  • License2 · Dec 2024 to Mar 2025
  • Research and development expense1 · Dec 2024

Segments

113 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement geographical10 members · 71 facts

  • CN12 · Jun 2024 to Jun 2026
  • JP12 · Jun 2024 to Jun 2026
  • US11 · Sep 2024 to Jun 2026
  • New York City10 · Dec 2021 to Mar 2026
  • San Francisco10 · Dec 2021 to Mar 2026
  • Cn5 · Sep 2024 to Dec 2025
  • Jp5 · Sep 2024 to Dec 2025
  • MA4 · Dec 2024 to Mar 2026
  • China And Japan1 · Jun 2024
  • Us1 · Jun 2025

Product or service6 members · 42 facts

  • License13 · Jun 2024 to Jun 2026
  • Product11 · Jun 2024 to Jun 2026
  • Research And Development Service Revenue9 · Jun 2024 to Jun 2026
  • Product Revenue7 · Mar 2025 to Jun 2026
  • License Revenue1 · Dec 2024
  • Royalty Revenue1 · Mar 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

1 calls · Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 6, 2026

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Nuvation Bio Inc. (NUVB) data · FactIQ